L. Président-du-jury-mr-le-pr and . Lecuru, également directeur de mon mémoire de DES, pour son encadrement dans mes travaux scientifiques mais aussi pour ses enseignements d'excellent chirurgien

C. Mon-directeur-de-thèse-mr-le-dr and . Huchon, co-directeur également de mon mémoire de DES que je remercie pour ses grandes qualités de statisticien

M. Les, P. Darai, and . Rouzier, grands noms de la chirurgie gynécologique qui me font l'honneur de faire partie de mon jury

E. Mr-le-dr and . Vincens, avec qui j'ai eu le privilège de travailler durant deux semestres au cours de mon internat

K. Au-dr, pour sa disponibilité et ses encouragements, sa volonté de me voir aller plus loin

T. Au-dr, collègue et néanmoins ami, pour ses enseignements en urologie mais aussi pour sa bonne humeur

. Au-drs-fraleu-louer, Barei et Blanche pour m'avoir enseigné la chirurgie digestive

A. Bensaid and . Bats, des modèles pour la suite

A. Sauvan, amie et collègue, à nos parcours conjoints depuis l'école de danse de notre petite ville de province

F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. Woronoff et al., Cancer incidence and mortality in France over the 1980???2012 period: Solid tumors, Revue d'??pid??miologie et de Sant?? Publique, vol.62, issue.2, pp.95-108, 2014.
DOI : 10.1016/j.respe.2013.11.073

S. Cannistra, Cancer of the Ovary, New England Journal of Medicine, vol.351, issue.24, pp.2519-2548, 2004.
DOI : 10.1056/NEJMra041842

G. Stuart, H. Kitchener, M. Bacon, A. Dubois, M. Friedlander et al., 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer, International Journal of Gynecological Cancer, vol.21, issue.4, pp.750-755, 2010.
DOI : 10.1097/IGC.0b013e31821b2568

D. Chi, E. Eisenhauer, J. Lang, J. Huh, L. Haddad et al., What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?, Gynecologic Oncology, vol.103, issue.2, pp.559-64, 2006.
DOI : 10.1016/j.ygyno.2006.03.051

R. Bristow, I. Puri, and D. Chi, Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis, Gynecologic Oncology, vol.112, issue.1, pp.265-74, 2009.
DOI : 10.1016/j.ygyno.2008.08.033

K. Shih and D. Chi, Maximal cytoreductive effort in epithelial ovarian cancer surgery, Journal of Gynecologic Oncology, vol.21, issue.2, pp.75-80, 2010.
DOI : 10.3802/jgo.2010.21.2.75

H. Hertel, H. Diebolder, J. Herrmann, C. Köhler, R. Kühne-heid et al., Is the Decision for Colorectal Resection Justified by Histopathologic Findings: A Prospective Study of 100 Patients with Advanced Ovarian Cancer, Gynecologic Oncology, vol.83, issue.3, pp.481-485, 2001.
DOI : 10.1006/gyno.2001.6338

C. Hudson, A RADICAL OPERATION FOR FIXED OVARIAN TUMOURS, BJOG: An International Journal of Obstetrics and Gynaecology, vol.207, issue.11, pp.1155-60, 1968.
DOI : 10.1111/j.1471-0528.1968.tb02901.x

R. Bristow, M. Del-carmen, H. Kaufman, and F. Montz, Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer, Journal of the American College of Surgeons, vol.197, issue.4, pp.565-74, 2003.
DOI : 10.1016/S1072-7515(03)00478-2

S. Mourton, L. Temple, N. Abu-rustum, M. Gemignani, Y. Sonoda et al., Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer, Gynecologic Oncology, vol.99, issue.3, pp.608-622, 2005.
DOI : 10.1016/j.ygyno.2005.07.112

R. Clayton, A. Obermair, I. Hammond, Y. Leung, and A. Mccartney, The Western Australian Experience of the Use of en Bloc Resection of Ovarian Cancer with Concomitant Rectosigmoid Colectomy, Gynecologic Oncology, vol.84, issue.1, pp.53-60, 2002.
DOI : 10.1006/gyno.2001.6469

A. Obermair, S. Hagenauer, D. Tamandl, R. Clayton, J. Nicklin et al., Safety and Efficacy of Low Anterior en Bloc Resection as Part of Cytoreductive Surgery for Patients with Ovarian Cancer, Gynecologic Oncology, vol.83, issue.1, pp.115-135, 2001.
DOI : 10.1006/gyno.2001.6353

D. Richardson, A. Mariani, and W. Cliby, Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer, Gynecologic Oncology, vol.103, issue.2, pp.667-72, 2006.
DOI : 10.1016/j.ygyno.2006.05.003

G. Houvenaeghel, M. Gutowski, M. Buttarelli, J. Cuisenier, F. Narducci et al., Modified Posterior Pelvic Exenteration for Ovarian Cancer, International Journal of Gynecological Cancer, vol.183, issue.5, pp.968-73, 2009.
DOI : 10.1111/IGC.0b013e3181a7f38b

N. Gillette-cloven, R. Burger, B. Monk, D. Mcmeekin, S. Vasilev et al., Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer1 1No competing interests declared., Journal of the American College of Surgeons, vol.193, issue.6, pp.626-658, 2001.
DOI : 10.1016/S1072-7515(01)01090-0

M. Buttarelli, G. Houvenaeghel, L. Lelièvre, J. Jacquemier, J. Guiramand et al., Une exent??ration pelvienne post??rieure avec??anastomose est-elle faisable et??justifi??e dans??le??traitement des??cancers de??l'ovaire ????un??stade ??volu?????, Annales de Chirurgie, vol.131, issue.8, pp.431-437, 2006.
DOI : 10.1016/j.anchir.2006.03.017

W. Barnes, J. Johnson, S. Waggoner, J. Barter, R. Potkul et al., Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors, Gynecologic Oncology, vol.42, issue.2, pp.151-156, 1991.
DOI : 10.1016/0090-8258(91)90336-4

P. Benedetti-panici, F. Maneschi, G. Scambia, G. Cutillo, S. Greggi et al., The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma, Obstetrics & Gynecology, vol.87, issue.4, pp.532-540, 1996.
DOI : 10.1016/0029-7844(95)00494-7

J. Park, S. Seo, S. Kang, K. Lee, S. Lim et al., The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns, Gynecologic Oncology, vol.103, issue.3, pp.977-84, 2006.
DOI : 10.1016/j.ygyno.2006.06.004

M. Hoffman and E. Zervose, Colon resection for ovarian cancer: Intraoperative decisions, Gynecologic Oncology, vol.111, issue.2, pp.56-65, 2008.
DOI : 10.1016/j.ygyno.2008.07.055

A. Revaux, R. Rouzier, M. Ballester, F. Selle, E. Daraï et al., Comparison of Morbidity and Survival Between Primary and Interval Cytoreductive Surgery in Patients After Modified Posterior Pelvic Exenteration for Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.22, issue.8, pp.1349-54, 2012.
DOI : 10.1097/IGC.0b013e318265d358

M. Frasson, B. Flor-lorente, R. Rodríguez, J. Granero-castro, P. Hervás et al., Risk Factors for Anastomotic Leak After Colon Resection for Cancer, Annals of Surgery, vol.262, issue.2, 2014.
DOI : 10.1097/SLA.0000000000000973

M. Peiretti, R. Bristow, I. Zapardiel, M. Gerardi, V. Zanagnolo et al., Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes, Gynecologic Oncology, vol.126, issue.2, pp.220-223, 2012.
DOI : 10.1016/j.ygyno.2012.04.030

S. Dhayat and N. Senninger, Predictors for Anastomotic Leak After Colorectal Resection, Annals of Surgery, vol.261, issue.6, 2013.
DOI : 10.1097/SLA.0000000000000458

R. Burger, M. Sill, B. Monk, B. Greer, and J. Sorosky, Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study, Journal of Clinical Oncology, vol.25, issue.33, pp.5165-71, 2007.
DOI : 10.1200/JCO.2007.11.5345

S. Cannistra, U. Matulonis, R. Penson, J. Hambleton, J. Dupont et al., Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer, Journal of Clinical Oncology, vol.25, issue.33, pp.5180-5186, 2007.
DOI : 10.1200/JCO.2007.12.0782

R. Burger, M. Brady, M. Bookman, G. Fleming, B. Monk et al., Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2473-83, 2011.
DOI : 10.1056/NEJMoa1104390

T. Perren, A. Swart, J. Pfisterer, J. Ledermann, E. Pujade-lauraine et al., A Phase 3 Trial of Bevacizumab in Ovarian Cancer, New England Journal of Medicine, vol.365, issue.26, pp.2484-96, 2011.
DOI : 10.1056/NEJMoa1103799

T. Bège, B. Lelong, F. Viret, O. Turrini, J. Guiramand et al., Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients, Annals of Surgical Oncology, vol.97, issue.2
DOI : 10.1245/s10434-008-0279-2

R. Salani, M. Zahurak, A. Santillan, R. Giuntoli, and R. Bristow, Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: A case???control study, Gynecologic Oncology, vol.107, issue.3, pp.495-504, 2007.
DOI : 10.1016/j.ygyno.2007.08.003

E. Chéreau, E. Lambaudie, and G. Houvenaeghel, Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.23, issue.7, pp.1326-1356, 2013.
DOI : 10.1097/IGC.0b013e31829dc923

J. Classe, E. Cerato, C. Boursier, J. Dauplat, C. Pomel et al., Impact des curages r??trop??riton??aux sur la survie des patientes atteintes d???un cancer de l???ovaire ?? un stade avanc????: le protocole CARACO, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.3, pp.201-205, 2011.
DOI : 10.1016/j.jgyn.2011.02.009

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.205-218, 2004.
DOI : 10.1097/01.sla.0000133083.54934.ae

P. Yoon, V. Chalasani, and H. Woo, Use of Clavien-Dindo Classification in Reporting and Grading Complications after Urological Surgical Procedures: Analysis of 2010 to 2012, The Journal of Urology, vol.190, issue.4, pp.1271-1275, 2013.
DOI : 10.1016/j.juro.2013.04.025

P. Krarup, A. Nordholm-carstensen, L. Jorgensen, and H. Harling, Anastomotic Leak Increases Distant Recurrence and Long-Term Mortality After Curative Resection for Colonic Cancer, Annals of Surgery, vol.259, issue.5, pp.930-938, 2014.
DOI : 10.1097/SLA.0b013e3182a6f2fc

S. Salvans, X. Mayol, S. Alonso, R. Messeguer, M. Pascual et al., Postoperative Peritoneal Infection Enhances Migration and Invasion Capacities of Tumor Cells In Vitro, Annals of Surgery, vol.260, issue.5, pp.939-982, 2014.
DOI : 10.1097/SLA.0000000000000958

K. Trencheva, K. Morrissey, M. Wells, C. Mancuso, S. Lee et al., Identifying Important Predictors for Anastomotic Leak After Colon and Rectal Resection, Annals of Surgery, vol.257, issue.1, pp.108-121, 2013.
DOI : 10.1097/SLA.0b013e318262a6cd

D. Silver, B. Zgheib, and N. , Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and considerations, Gynecologic Oncology, vol.114, issue.3, pp.427-457, 2009.
DOI : 10.1016/j.ygyno.2009.05.037

E. Kalogera, S. Dowdy, A. Mariani, A. Weaver, G. Aletti et al., Multiple large bowel resections: Potential risk factor for anastomotic leak, Gynecologic Oncology, vol.130, issue.1, pp.213-221, 2013.
DOI : 10.1016/j.ygyno.2013.04.002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686884

A. Montedori, R. Cirocchi, E. Farinella, F. Sciannameo, and I. Abraha, Covering ileo-or colostomy in anterior resection for rectal carcinoma, Cochrane Database Syst Rev, issue.5, p.6878, 2010.

M. Koskas, E. Chereau, M. Ballester, F. Selle, R. Rouzier et al., Wound complications after bevacizumab treatment in patients operated on for ovarian cancer, Anticancer Res. nov, vol.30, issue.11, pp.4743-4750, 2010.

G. Aletti, S. Dowdy, K. Podratz, and W. Cliby, Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, American Journal of Obstetrics and Gynecology, vol.197, issue.6
DOI : 10.1016/j.ajog.2007.10.495

S. Eisenkop and N. Spirtos, Procedures Required to Accomplish Complete Cytoreduction of Ovarian Cancer: Is There a Correlation with ???Biological Aggressiveness??? and Survival?, Gynecologic Oncology, vol.82, issue.3, pp.435-476, 2001.
DOI : 10.1006/gyno.2001.6313